Cognitive disorders and antiphospholipid antibodies.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Autoimmunity Reviews

• Publication date

  2016-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.autrev.2016.09.002PMID 27639839
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Functional Magnetic Resonance Imaging of Working Memory and Executive Dysfunction in Systemic Lupus Erythematosus and Antiphospholipid Antibody–Positive Patients

  2016cited by this paper
• Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome

  2016cited by this paper
• Mice with experimental antiphospholipid syndrome display hippocampal dysfunction and a reduction of dendritic complexity in hippocampal CA1 neurones

  2015cited by this paper
• The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus erythematosus

  2015cited by this paper
• The relevance of "non-criteria" clinical manifestations of antiphospholipid syndrome: 14th International Congress on Antiphospholipid Antibodies Technical Task Force Report on Antiphospholipid Syndrome Clinical Features.

  2015cited by this paper
• Vectra DA for the objective measurement of disease activity in patients with rheumatoid arthritis.

  2014cited by this paper
• Neurological antiphospholipid syndrome: Clinical, neuroimaging, and pathological characteristics.

  2014cited by this paper
• Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice.

  2014cited by this paper
• Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.

  2014cited by this paper
• Neurological manifestations in patients with antiphospholipid syndrome

  2013cited by this paper
• A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients

  2013cited by this paper
• Antiphospholipid Antibodies, Brain Infarcts, and Cognitive and Motor Decline in Aging (ABICMA): Design of a Community-Based, Longitudinal, Clinical-Pathological Study

  2012cited by this paper
• Neurocognitive Dysfunction in Systemic Lupus Erythematosus: Association with Antiphospholipid Antibodies, Disease Activity and Chronic Damage

  2012cited by this paper
• Cognitive Dysfunction and Antiphospholipid Antibodies

  2012cited by this paper
• Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort.

  2012cited by this paper
• Cardiovascular disease and cognitive dysfunction in systemic lupus erythematosus

  2012cited by this paper
• Antiphospholipid syndrome induction exacerbates a transgenic Alzheimer disease model on a female background.

  2011cited by this paper
• Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome.

  2011cited by this paper
• Neuroimaging evidence of white matter inflammation in newly diagnosed systemic lupus erythematosus.

  2011cited by this paper
• Depression and Cognitive Impairment in Newly Diagnosed Systemic Lupus Erythematosus

  2010cited by this paper
• Moderate versus high-titer persistently anticardiolipin antibody positive patients: Are they clinically different and does high-titer anti-β2-glycoprotein-I antibody positivity offer additional predictive information?

  2010cited by this paper
• General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus.

  2007cited by this paper
• Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.

  2006cited by this paper
• International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)

  2006cited by this paper
• Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus.

  2005cited by this paper
• Predictors of cognitive dysfunction in patients with systemic lupus erythematosus

  2005cited by this paper
• Elimination of anticardiolipin antibodies and cessation of cognitive decline in a UV-A1-irradiated systemic lupus erythematosus patient

  2005cited by this paper
• Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients.

  2005cited by this paper
• Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.

  2004cited by this paper
• Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.

  2004cited by this paper
• Neuropsychiatric lupus syndromes

  2003cited by this paper
• Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.

  2003cited by this paper
• Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.

  2002cited by this paper
• Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions

  2002cited by this paper
• Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants.

  2002cited by this paper
• Hyperactivity in a mouse model of the antiphospholipid syndrome

  2001cited by this paper
• Dementia and Antiphospholipid Antibodies

  2000cited by this paper
• A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus.

  1999cited by this paper
• The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes.

  1999cited by this paper
• A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus.

  1999cited by this paper
• Neuropsychological deficits associated with antiphospholipid antibodies.

  1999cited by this paper
• Neurological dysfunction and hyperactive behavior associated with antiphospholipid antibodies. A mouse model.

  1997cited by this paper
• The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus

  1997cited by this paper
• Anticardiolipin antibodies in normal subjects. Neuropsychological correlates and MRI findings.

  1995cited by this paper
• Anticardiolipin antibodies in two elderly subpopulations

  1995cited by this paper
• Higher cortical dysfunction, antiphospholipid antibodies and neuroradiological examinations in systemic lupus erythematosus.

  1992cited by this paper

• Advanced neuroimaging in systemic lupus erythematosus: identifying biomarkers for cognitive dysfunction

  2025cites this paper
• Functional Brain Networks Related to Processing Speed and Memory in Systemic Lupus Erythematosus: A Connectome-Based Modeling Study.

  2025cites this paper
• Attribution of psychiatric manifestations to systemic lupus erythematosus in Chinese patients: A retrospective study

  2025cites this paper
• Cognitive Function and the Consumption of Probiotic Foods: A National Health and Nutrition Examination Survey Study

  2024cites this paper
• The hemostatic system in chronic brain diseases: A new challenging frontier?

  2024cites this paper
• Neurovascular Issues in Antiphospholipid Syndrome: Arterial Vasculopathy from Small to Large Vessels in a Neuroradiological Perspective

  2024cites this paper
• Cognitive impairment in a Colombian cohort of patients with systemic lupus erythematosus: A cross-sectional study

  2024cites this paper
• The impact of antiphospholipid antibodies/antiphospholipid syndrome on systemic lupus erythematosus.

  2024cites this paper
• Neurological involvement in patients with systemic autoimmune rheumatic diseases: a descriptive study in an Egyptian cohort

  2024cites this paper
• Non-pharmacological rehabilitation interventions for individuals with antiphospholipid syndrome: A scoping review

  2023cites this paper
• [Mental disorders in patients with systemic lupus erythematosus: association with activity and the course of rheumatic disease].

  2023cites this paper
• The conundrum of neuropsychiatric systemic lupus erythematosus: Current and novel approaches to diagnosis

  2023cites this paper
• Association of mycophenolate and azathioprine use with cognitive function in systemic lupus.

  2022cites this paper
• Cognitive Impairment in Anti-Phospholipid Syndrome and Anti-Phospholipid Antibody Carriers

  2022influential citation
• Cognitive dysfunction and associated neuroimaging biomarkers in antiphospholipid syndrome: a systematic review

  2021cites this paper
• Cognitive Impairment in SLE: Mechanisms and Therapeutic Approaches

  2021cites this paper
• Antiphospholipid syndrome in pregnancy: Neuro-psychiatric aspects

  2021cites this paper
• Assessment of Cognitive Function in Systemic Lupus Erythematosus

  2021cites this paper
• Primary Psychiatric Disorder Masking the Diagnosis of Lupus Cerebritis

  2020cites this paper
• Definition and treatment approach of non-criteria clinical manifestations of antiphospholipid syndrome.

  2020cites this paper
• Психические расстройства и когнитивные нарушения у больных антифосфолипидным синдромом

  2020cites this paper
• [Mental disorders and cognitive impairment in patients with antiphospholipid syndrome].

  2020cites this paper
• Cognitive Dysfunction in Systemic Lupus Erythematosus: A Case for Initiating Trials

  2019influential citation
• Relationship of Antiphospholipid Antibodies to Risk of Dementia: A Systematic Review

  2019cites this paper
• Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis

  2018cites this paper
• Diagnostic approach to neuropsychiatric lupus erythematosus: what should we do?

  2018cites this paper
• Decreased hippocampal cell proliferation in mice with experimental antiphospholipid syndrome

  2018cites this paper
• Olfactory function in systemic lupus erythematosus and systemic sclerosis. A longitudinal study and review of the literature.

  2018cites this paper
• Late diagnosis of systemic lupus erythematosus and antiphospholipid syndrome in an older woman with psychosis: a case report and review of the literature

  2017influential citation
• Central Nervous System Manifestations of Antiphospholipid Syndrome.

  2017influential citation
• An Unusual Case of Diabetes Mellitus: Ketone-Positive Hyperglycaemia Induced Hemichorea-Hemiballism

  2017cites this paper
• Autoimmunity in 2016

  2017cites this paper
• Title : The impact of antiphospholipid antibodies/antiphospholipid syndrome on SLE

  year unknowncites this paper